Delayed
Hong Kong S.E.
09:20:49 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
9.01
HKD
|
+0.22%
|
|
-23.03%
|
-31.06%
|
Fiscal Period: December |
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,045
|
6,045
|
-
|
Enterprise Value (EV)
1 |
8,621
|
4,722
|
4,467
|
P/E ratio
|
38.2
x
|
16.7
x
|
11.7
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.61
x
|
1.69
x
|
1.35
x
|
EV / Revenue
|
2.61
x
|
1.32
x
|
1
x
|
EV / EBITDA
|
12.3
x
|
6.41
x
|
4.74
x
|
EV / FCF
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
Price to Book
|
3.59
x
|
2.95
x
|
2.3
x
|
Nbr of stocks (in thousands)
|
727,355
|
727,355
|
-
|
Reference price
2 |
8.311
|
8.311
|
8.311
|
Announcement Date
|
3/28/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
3,298
|
3,567
|
4,474
|
EBITDA
1 |
-
|
701.9
|
736.2
|
941.8
|
EBIT
1 |
-
|
534.4
|
596.5
|
775.3
|
Operating Margin
|
-
|
16.21%
|
16.72%
|
17.33%
|
Earnings before Tax (EBT)
1 |
-
|
349.4
|
504.2
|
785.5
|
Net income
1 |
680.8
|
234.9
|
375.3
|
549.3
|
Net margin
|
-
|
7.12%
|
10.52%
|
12.28%
|
EPS
2 |
0.9600
|
0.3100
|
0.4977
|
0.7100
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
Announcement Date
|
6/19/23
|
3/28/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
1,378
|
1,323
|
1,578
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
33.5%
|
20.7%
|
22.2%
|
ROA (Net income/ Total Assets)
|
-
|
8.25%
|
6.9%
|
9.58%
|
Assets
1 |
-
|
4,748
|
5,438
|
5,735
|
Book Value Per Share
2 |
-
|
2.320
|
2.810
|
3.620
|
Cash Flow per Share
2 |
-
|
0.6100
|
0.5400
|
1.000
|
Capex
1 |
-
|
248
|
322
|
410
|
Capex / Sales
|
-
|
6.99%
|
9.03%
|
9.17%
|
Announcement Date
|
6/19/23
|
3/28/24
|
-
|
-
|
Last Close Price
8.311
CNY Average target price
14.35
CNY Spread / Average Target +72.69% Consensus |
1st Jan change
|
Capi.
|
---|
| -31.06% | 853M | | -17.21% | 8.46B | | +45.61% | 3.88B | | -36.69% | 2.63B | | -8.06% | 2.45B | | -9.64% | 2.31B | | -6.49% | 1.99B | | -17.24% | 1.61B | | -37.21% | 1.3B | | +5.14% | 1.09B |
Medical & Diagnostic Laboratories
|